AstraZeneca will implement new surveillance upgrades to its research and ... AstraZeneca’s Gaithersburg campus is home to nearly 3,500 ... MD loses the most federal jobs in nearly 30 ...

Prominent cancer researcher José Baselga, MD, PhD, FASCO, who served as head of oncology research and development for AstraZeneca, has died at age 61 years, the company announced in a press ...

WILMINGTON, DE — AstraZeneca is advancing its global efforts to transform cancer care by presenting pivotal data from its oncology portfolio at the American Society of Clinical Oncology (ASCO ...

Through its re-upped pact with AstraZeneca, Immunai is slated to receive $18 million for the first phase of the new project. The collaboration as a whole will focus on identifying which patients ...

Interim Phase 2 data reported at the annual meeting of the American Society of Clinical Oncology suggest the AstraZeneca and Daiichi Sankyo drug has potential to treat many of these cancers. By ...

AstraZeneca AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 41% of AstraZeneca‘s total revenues) rose 13% in the first quarter of 2025, generating ...

WASHINGTON, April 19, 2021 /PRNewswire/ -- The Access to Comprehensive Genomic Profiling Coalition (ACGP) announced today the addition of AstraZeneca, Loxo Oncology at Lilly, and Invitae ...

AstraZeneca said its Enhertu cancer drug has been shown to significantly help women suffering from a type of breast cancer that leaves them with poor treatment options, opening the door to a much ...

AstraZeneca PLC said Monday that it has entered into an oncology collaboration with Daiichi Sankyo Co. worth up to $6 billion that it said could redefine treatment standards in lung, breast and ...